Endocrinology

LeVee A, Peluso E, Lechner MG, Ruel N, Mortimer J, Kang I, Tsai K. Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in[...]

Duru OK, Harwood J, Moin T, Takada S, Tseng CH, Saju R, Lee E, Fatehpuria A, Mangione CM. Care Coordination for High-Need, High-Cost Commercially Insured[...]

Zhang D, Tsai K, Santana C, Javaherian K, Lee M, Bergsneider M, Kim W, Wang MB, Vinters HV, Yan W, Heaney AP. Genetic profiling of[...]

Isaacs D, Kashefi M, Downs I, Weinreb J. A Veteran Presenting With Symptomatic Postprandial Episodes. Fed Pract. 2025 Feb;42(2):1-6. doi: 10.12788/fp.0541. Epub 2025 Feb 18.[...]

Raverot G, Burman P, Abreu AP, Heaney AP, van Hulsteijn L, Lin AL, Marcus H, McCormack A, Minniti G, Petersenn S, Popovic V, Theodoropoulou M,[...]

Yu R. Specific imaging features of sellar atypical teratoid/rhabdoid tumor or the lack of thereof. World J Radiol. 2025 May 28;17(5):106975. doi: 10.4329/wjr.v17.i5.106975. PMID: 40503480;[...]

Yu R. Importance of symptoms acuity for clinical diagnosis of primary sellar atypical teratoid/rhabdoid tumor. World J Clin Oncol. 2025 May 24;16(5):106292. doi: 10.5306/wjco.v16.i5.106292. PMID:[...]

Peng D, Dong E, Martinez D, Kang Y, Wong D, Holland V. Cutaneous manifestation of metastatic papillary thyroid carcinoma. JAAD Case Rep. 2025 Apr 11;60:129-131.[...]

Wilson JB, Hoang TD, Lee ML, Epstein M, Friedman TC. Reverse T3 in patients with hypothyroidism on different thyroid hormone replacement. PLoS One. 2025 Jun[...]

The UCLA Department of Medicine is pleased to share that Chair and Executive Medical Director E. Dale Abel, MD, PhD was the recipient of the Keith Reimer[...]